Cue Biopharma Inc (CUE)
1.01
-0.03
(-2.88%)
USD |
NASDAQ |
Dec 24, 16:00
Cue Biopharma Cash from Investing (Quarterly): 0.098M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -16.16M |
| Arbutus Biopharma Corp | -11.99M |
| GlycoMimetics Inc | 0.00 |
| FibroGen Inc | 0.755M |
| Cidara Therapeutics Inc | -0.106M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.527M |
| Cash from Financing (Quarterly) | 9.821M |
| Free Cash Flow | -38.32M |
| Free Cash Flow Per Share (Quarterly) | -0.1469 |
| Free Cash Flow to Equity (Quarterly) | -6.568M |
| Free Cash Flow Yield | -76.63% |